It is the physical devices, components and consumable items that touch or interact with the sample that can have the greatest impact on measurement or result quality.
In a world where scientific measurements contribute to the understanding of our wellbeing, the techniques of LCMS (liquid chromatography mass spectrometry) and GCMS (gas chromatography mass spectrometry) are playing an increasingly important role.
These technologies enable the detection and measurement of such a diverse range of targets; from the proteins in our body and their function, to the outputs of our metabolic processes, to the presence and level of critical ‘biomarkers’ in blood through to the detection of toxic pollutants and contaminants in our biology, food and the environment.
At Trajan we imagine that increasingly healthcare decisions will be based on such measurements. Not just one measurement at a single point in time, but rather many measurements, over time, and/or across populations.
Our focus is to develop and deliver to the world the technologies that improve the quality, and accelerate the accessibility, of those measurements. We believe the quality of the measurement-based healthcare decisions of the future can only be as good as the quality of the underlying data, especially once machine learning technologies are deployed across massive datasets.